# Novartis **Entity class:** Technology, concept, or ecosystem entity **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] ## Definition **Novartis** is represented in the supplied neurotechnology ecosystem graph through the source-qualified relationships below. This page preserves the graph's direction, predicate, evidence key, and epistemic status without treating technical similarity as ownership, funding, licensing, or organizational identity. <!-- BEGIN NEUROTECH RELATIONSHIP GRAPH 2026-09-10 --> ## Relationships ### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Incoming typed edges - **Edge 50 — [[wiki/Cyril Eleftheriou|Cyril Eleftheriou]] `former_affiliation` → this entry** — **VERIFIED**; evidence `SUB_ABOUT`. Pharma/neuroengineering bridge. #### Epistemic boundary `VERIFIED`, `VERIFIED_SECONDARY`, `CORPUS`, `STRONG_TECHNICAL_LINEAGE`, `STRONG_TECHNICAL_CONVERGENCE`, `ANALYTIC`, and `UNRESOLVED` are retained as distinct relation states. An edge does not imply ownership, control, funding, licensing, technology transfer, or organizational identity unless its predicate and evidence state that relationship explicitly. <!-- END NEUROTECH RELATIONSHIP GRAPH 2026-09-10 -->